Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Heliyon
|
May 29, 2024
A cross-sectional study of optometrists' attitudes towards dry eye disease management in Hong Kong: A web-based survey in Hong Kong
Ka Yin Chan, Biyue Guo, Jimmy Sh Tse, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
December 5, 2021
Establishment and characterization of meningioma patient-derived organoid
Henry Siu Cheung Chan, Ho Keung Ng, Aden Ka-Yin Chan, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association
|
August 3, 2024
Ocular surface parameters repeatability and agreement -A comparison between Keratograph 5M and IDRA
Ka Yin Chan, Xulin Liao, Biyue Guo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 16, 2017
The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis
Kay Ka-Wai Li, Yan Qi, Tian Xia, et al.
Neuro-Oncology
|
September 7, 2017
Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas
Zhenyu Zhang, Aden Ka-Yin Chan, Xiaojie Ding, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association
|
March 29, 2021
CLEAR - Orthokeratology
Stephen J Vincent, Pauline Cho, Ka Yin Chan, et al.
Critical Reviews in Oncology/Hematology
|
December 5, 2017
TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data
Huy Gia Vuong, Ahmed M A Altibi, Uyen N P Duong, et al.
Brain Pathology (Zurich, Switzerland)
|
December 21, 2012
MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L
Kay Ka-Wai Li, Ling Yang, Jesse Chung-Sean Pang, et al.
Plos One
|
July 11, 2013
Mutation analysis of IDH1 in paired gliomas revealed IDH1 mutation was not associated with malignant progression but predicted longer survival
Yu Yao, Aden Ka-Yin Chan, Zhi Yong Qin, et al.
International Journal of Clinical and Experimental Pathology
|
December 1, 2015
TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline
Ze-Lin Sun, Aden Ka-Yin Chan, Ling-Chao Chen, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Heliyon
|
May 29, 2024
A cross-sectional study of optometrists' attitudes towards dry eye disease management in Hong Kong: A web-based survey in Hong Kong
Ka Yin Chan, Biyue Guo, Jimmy Sh Tse, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
December 5, 2021
Establishment and characterization of meningioma patient-derived organoid
Henry Siu Cheung Chan, Ho Keung Ng, Aden Ka-Yin Chan, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association
|
August 3, 2024
Ocular surface parameters repeatability and agreement -A comparison between Keratograph 5M and IDRA
Ka Yin Chan, Xulin Liao, Biyue Guo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 16, 2017
The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis
Kay Ka-Wai Li, Yan Qi, Tian Xia, et al.
Neuro-Oncology
|
September 7, 2017
Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas
Zhenyu Zhang, Aden Ka-Yin Chan, Xiaojie Ding, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association
|
March 29, 2021
CLEAR - Orthokeratology
Stephen J Vincent, Pauline Cho, Ka Yin Chan, et al.
Critical Reviews in Oncology/Hematology
|
December 5, 2017
TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data
Huy Gia Vuong, Ahmed M A Altibi, Uyen N P Duong, et al.
Brain Pathology (Zurich, Switzerland)
|
December 21, 2012
MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L
Kay Ka-Wai Li, Ling Yang, Jesse Chung-Sean Pang, et al.
Plos One
|
July 11, 2013
Mutation analysis of IDH1 in paired gliomas revealed IDH1 mutation was not associated with malignant progression but predicted longer survival
Yu Yao, Aden Ka-Yin Chan, Zhi Yong Qin, et al.
International Journal of Clinical and Experimental Pathology
|
December 1, 2015
TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline
Ze-Lin Sun, Aden Ka-Yin Chan, Ling-Chao Chen, et al.
Page
of 5